Amb a 1-specific CD4+ T-cell receptor (Amb a 1-specific TCR)

Amb a 1-specific CD4+ T-cell receptors are specialized protein complexes found on the surface of T helper cells that play a pivotal role in the allergic response to short ragweed (Ambrosia artemisiifolia) pollen. These receptors specifically recognize processed peptides of the Amb a 1 protein, the primary allergen in ragweed, when presented by Major Histocompatibility Complex (MHC) class II molecules on antigen-presenting cells [1][2]. In sensitized individuals, the engagement of these TCRs typically promotes a Th2-biased immune environment, characterized by the secretion of pro-inflammatory cytokines like IL-4 and IL-13, which drive IgE production and allergic inflammation [3]. Therapeutic interventions, such as allergen immunotherapy (AIT), target the signaling and population dynamics of these TCR-bearing cells to induce immunological tolerance [4]. By repeatedly exposing the immune system to controlled doses of Amb a 1, these treatments aim to shift the T-cell population toward a regulatory phenotype (Tregs) or induce anergy, thereby reducing the clinical symptoms of allergic rhinitis and asthma [5]. Monitoring the frequency and diversity of these receptors serves as a critical biomarker for assessing the efficacy of desensitization therapies [6].

Other names

Ragweed allergen-specific T-cell receptorAmb a 1-reactive T-cell receptorShort ragweed allergen-specific TCRAmb a 1-specific CD4+ TCR

Allergen immunotherapy (AIT) modulates these receptors by inducing T-cell anergy, deletion, or the differentiation of regulatory T cells (Tregs), shifting the immune response from a Th2-driven allergic state to a tolerant or Th1-skewed state [4][5].